HIGHLIGHTS
- who: Anthony S. Padula from the Laboratory monitoring is not mandated in this observational registry have published the paper: The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry, in the Journal: (JOURNAL)
- what: The findings of this study have potential clinical implications.
- how: The CorEvitas RA registry is an independent prospective national observational cohort in which treatment and outcome data are collected from both rheumatologists and patients at the time of a clinical encounter (approximately every 6 months). This study was carried . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.